Tod Smeal
Technik-/Wissenschafts-/F&E-Leiter bei CARDIFF ONCOLOGY, INC.
Vermögen: - $ am 30.04.2024
Profil
Tod Smeal is currently the Chief Scientific Officer at Cardiff Oncology, Inc. He previously held positions as the Director-Oncology Research Unit at Pfizer Inc. from 2003 to 2015, the Chief Scientific Officer at Eli Lilly & Co. from 2015 to 2020, and the Chief Scientific Officer at Hexagon Bio, Inc. from 2020 to 2021.
Dr. Smeal obtained his undergraduate degree from the Massachusetts Institute of Technology and his doctorate degree from the University of California San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC.
-.--% | 07.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Tod Smeal
| Unternehmen | Position | Beginn |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.01.2022 |
Ehemalige bekannte Positionen von Tod Smeal
| Unternehmen | Position | Ende |
|---|---|---|
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
| ELI LILLY AND COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2015 |
Ausbildung von Tod Smeal
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Health Technology |